Skip to main content
Advertisement
American Heart Association
Science Volunteer
Warning Signs
Search for this keyword
Search
Advanced Search
Donate
Home
About this Journal
Editorial Board
General Statistics
Author Reprints
Commercial Reprints
Customer Service and Ordering Information
Information for Advertisers
All Issues
Subjects
All Subjects
Arrhythmia and Electrophysiology
Basic, Translational, and Clinical Research
Critical Care and Resuscitation
Epidemiology, Lifestyle, and Prevention
Genetics
Heart Failure and Cardiac Disease
Hypertension
Imaging and Diagnostic Testing
Intervention, Surgery, Transplantation
Quality and Outcomes
Stroke
Vascular Disease
Browse Features
Editor Picks
Blogging Stroke
AHA/ASA Guidelines and Statements
ISC and Nursing Symposium Abstracts
Progress and Innovation Award Recipients
Acknowledgment of Reviewers
Stroke in Women
Outstanding Reviewers 2017
Resources
Online Submission/Peer Review
Instructions for Authors
→ Article Types
→ General Preparation Instructions
→ Research Guidelines
→ How to Submit a Manuscript
→ Tips for Submission
→ Links and Forms
→ Revised Manuscripts
Costs to Authors
Journal Policies
Wolters Kluwer Author Services
Early Career Resources
Stroke CME
Webinar Series
Permissions and Rights Q&A
AHA Newsroom
AHA Journals
AHA Journals Home
Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
Circulation
→ Circ: Arrhythmia and Electrophysiology
→ Circ: Genomic and Precision Medicine
→ Circ: Cardiovascular Imaging
→ Circ: Cardiovascular Interventions
→ Circ: Cardiovascular Quality & Outcomes
→ Circ: Heart Failure
Circulation Research
Hypertension
Stroke
Journal of the American Heart Association
Facebook
Twitter
My alerts
Sign In
Join
Search for this keyword
Search
Advanced search
Header Publisher Menu
American Heart Association
Science Volunteer
Warning Signs
Advanced Search
Donate
Stroke
My alerts
Sign In
Join
Facebook
Twitter
Home
About this Journal
Editorial Board
General Statistics
Author Reprints
Commercial Reprints
Customer Service and Ordering Information
Information for Advertisers
All Issues
Subjects
All Subjects
Arrhythmia and Electrophysiology
Basic, Translational, and Clinical Research
Critical Care and Resuscitation
Epidemiology, Lifestyle, and Prevention
Genetics
Heart Failure and Cardiac Disease
Hypertension
Imaging and Diagnostic Testing
Intervention, Surgery, Transplantation
Quality and Outcomes
Stroke
Vascular Disease
Browse Features
Editor Picks
Blogging Stroke
AHA/ASA Guidelines and Statements
ISC and Nursing Symposium Abstracts
Progress and Innovation Award Recipients
Acknowledgment of Reviewers
Stroke in Women
Outstanding Reviewers 2017
Resources
Online Submission/Peer Review
Instructions for Authors
→ Article Types
→ General Preparation Instructions
→ Research Guidelines
→ How to Submit a Manuscript
→ Tips for Submission
→ Links and Forms
→ Revised Manuscripts
Costs to Authors
Journal Policies
Wolters Kluwer Author Services
Early Career Resources
Stroke CME
Webinar Series
Permissions and Rights Q&A
AHA Newsroom
AHA Journals
AHA Journals Home
Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
Circulation
→ Circ: Arrhythmia and Electrophysiology
→ Circ: Genomic and Precision Medicine
→ Circ: Cardiovascular Imaging
→ Circ: Cardiovascular Interventions
→ Circ: Cardiovascular Quality & Outcomes
→ Circ: Heart Failure
Circulation Research
Hypertension
Stroke
Journal of the American Heart Association
Anticoagulants
Collections
>
Intervention, Surgery, Transplantation
>
Anticoagulants
You have access
Restricted access
Letter by Mojadidi et al Regarding Article, “Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis”
Mohammad K. Mojadidi
,
Muhammad O. Zaman
and
Nimesh K. Patel
Stroke.
2018;
49:
e212
,
originally published April 11, 2018
https://doi.org/10.1161/STROKEAHA.118.021403
Download PDF
You have access
Restricted access
Letter by Guijarro Regarding Article, “Cerebrovascular Outcomes With Proton Pump Inhibitors and Thienopyridines: A Systematic Review and Meta-Analysis”
Carlos Guijarro
Stroke.
2018;
49:
e169
,
originally published March 16, 2018
https://doi.org/10.1161/STROKEAHA.118.020990
Download PDF
You have access
Restricted access
Antiplatelet and Anticoagulant Agents for Secondary Prevention of Thromboembolic Events in People With Antiphospholipid Syndrome
Malgorzata M. Bala
,
Magdalena Celinska-Lowenhoff
,
Wojciech Szot
,
Agnieszka Padjas
,
Mateusz Kaczmarczyk
,
Mateusz J. Swierz
and
Anetta Undas
Stroke.
2018;
49:
e41-e42
,
originally published February 6, 2018
https://doi.org/10.1161/STROKEAHA.117.019900
Download PDF
You have access
Restricted access
Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation
A Systematic Review and Meta-Analysis
Marco Proietti
,
Imma Romanazzi
,
Giulio Francesco Romiti
,
Alessio Farcomeni
and
Gregory Y.H. Lip
Stroke.
2018;
49:
98-106
,
originally published November 22, 2017
https://doi.org/10.1161/STROKEAHA.117.018395
Download PDF
You have access
Restricted access
Should Patients With Ischemic Stroke or Transient Ischemic Attack With Atrial Fibrillation and Microbleeds Be Anticoagulated?
Ashkan Shoamanesh
,
Andreas Charidimou
,
Mukul Sharma
and
Robert G. Hart
Stroke.
2017;
48:
3408-3412
,
originally published November 7, 2017
https://doi.org/10.1161/STROKEAHA.117.018467
Download PDF
You have access
Restricted access
Hemorrhagic Transformation After Large Cerebral Infarction in Rats Pretreated With Dabigatran or Warfarin
Il Kwon
,
Sunho An
,
Jayoung Kim
,
Seung-Hee Yang
,
Joonsang Yoo
,
Jang-Hyun Baek
,
Hyo Suk Nam
,
Young Dae Kim
,
Hye Sun Lee
,
Hyun-Jung Choi
and
Ji Hoe Heo
Stroke.
2017;
48:
2865-2871
,
originally published September 13, 2017
https://doi.org/10.1161/STROKEAHA.117.017751
Download PDF
You have access
Restricted access
Response by Barreto and Grotta to Letter Regarding Article, “Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)”
Andrew D. Barreto
and
James C. Grotta
Stroke.
2017;
48:
e259
,
originally published July 28, 2017
https://doi.org/10.1161/STROKEAHA.117.018294
Download PDF
You have access
Restricted access
Emergency Coagulation Assessment During Treatment With Direct Oral Anticoagulants
Limitations and Solutions
Matthias Ebner
,
Ingvild Birschmann
,
Andreas Peter
,
Florian Härtig
,
Charlotte Spencer
,
Joachim Kuhn
,
Gunnar Blumenstock
,
Christine S. Zuern
,
Ulf Ziemann
and
Sven Poli
Stroke.
2017;
48:
2457-2463
,
originally published August 3, 2017
https://doi.org/10.1161/STROKEAHA.117.017981
Download PDF
You have access
Restricted access
Geographic Variation in the Use of Oral Anticoagulation Therapy in Stroke Prevention in Atrial Fibrillation
Inmaculada Hernandez
,
Samir Saba
and
Yuting Zhang
Stroke.
2017;
48:
2289-2291
,
originally published June 27, 2017
https://doi.org/10.1161/STROKEAHA.117.017683
Download PDF
You have access
Restricted access
To Treat or Not to Treat
Anticoagulants as Secondary Preventives to the Oldest Old With Atrial Fibrillation
Peter Appelros
,
Bahman Farahmand
,
Andreas Terént
and
Signild Åsberg
Stroke.
2017;
48:
1617-1623
,
originally published May 9, 2017
https://doi.org/10.1161/STROKEAHA.117.016902
Download PDF
Pages
1
2
3
4
5
6
7
8
9
…
38
Next
Page
Current Issue
Stroke
May 2018
,
Volume 49
,
Issue 5
Table of Contents
Table of Contents (PDF)
Cover (PDF)
About the Cover
Index by author
Search This Journal
Search for this keyword
Search
Related Collections
Anticoagulants
(536)
Behavioral/Psychosocial Treatment
(543)
Cardiovascular Surgery
(103)
Catheter-Based Coronary and Valvular Interventions
(21)
Compliance/Adherence
(47)
Constraint-Induced Movement Therapy
(2)
Nursing
(22)
Pacemaker
(7)
Percutaneous Coronary Intervention
(397)
Pharmacology
(105)
Rehabilitation
(633)
Revascularization
(168)
Stent
(47)
Transplantation
(14)
Treatment
(4110)
Advertisement
Advertisement
